RBC Capital raised the firm’s price target on Westlake (WLK) to $100 from $85 and keeps an Outperform rating on the shares as part of a broader research note previewing Q4 for Commodity Chemicals as part of a broader research note previewing Q4 for Commodity Chemicals, also saying the company is best positioned among its peers. The firm is positive on the company’s high visibility on 2026-27 earnings growth from non-market dependent cost reductions and having the most exposure to construction recovery, the analyst tells investors in a research note. Westlake’s lowest leverage minimizes risk and allows for opportunistic M&A and organic investment, RBC added.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake price target raised to $100 from $85 at Citi
- Westlake price target lowered to $82 from $83 at BofA
- Westlake price target raised to $88 from $82 at Mizuho
- Westlake Completes Acquisition of ACI/Perplastic Compounding Businesses
- Westlake completes acquisition of ACI compounding solutions business